Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 317-323

  Würl, Peter ^a   Taubert, Helge ^a   Bache, Matthias ^a   Kroll, Jens ^a   Meye, Axel ^a   Berger, Dieter ^a   Siermann, Anja ^a   Holzhausen, Hans Jürgen ^a   Hinze, Raoul ^a   Schmidt, Hannelore ^a   Rath, Friedrich Wilhelm ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; FIBROSARCOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; NEUROMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CODON; FIBROSARCOMA; GENES, P53; HUMANS; LEIOMYOSARCOMA; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, NERVE TISSUE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RHABDOMYOSARCOMA;

EID: 0345556004     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<317::AID-IJC14>3.0.CO;2-2     Document Type: Article

References (54)

1. ANDREASSEN, A., OYJORD, T., HOVIG, E., HOLM, R., FLORENES, V.A., NESLAND, J.M., MYKLEBOST, O. and HOIE, J., p53 abnormalities in different sub-types of human sarcomas. Cancer Res., 53, 468-471 (1993).
2. BOMAN, F., PETERS, J., RAGGE, N. and TRICHE, T., Infrequent mutation of the p53 gene in fibrous tumors of infancy and childhood. Diagn. mol. Pathol., 2, 14-22 (1994).
3. BROWN, R., MARSHALL, S.G., HALL, P. and HALL, A., Mechanism of activation of N-ras gene in human flbrosarcoma cell line HT1080. EMBO J., 3, 1321-1326 (1984).
4. BROWN, T., KENNARD, O., KNEALE, G. and RABINOVICH, D., High-resolution structure of a DNA helix containing mismatched base pairs. Nature (Lond.), 313, 604-606 (1985).
5. CASTRESANA, J.S., RUBIO, M.P., GOMEZ, L., KREICBERGS, A., ZETTERBERG, A. and BARRIOS, C., Detection of TP53-gene mutations in human sarcomas. Europ. J. Cancer, 31, 735-781 (1995).
6. CHARDIN, P., YERAMIAN, P., MADAULE, P. and TAVITIAN, A., N-ras-gene activation in the RD human rhabdomyosarcoma cell line. Int. J. Cancer, 35, 647-652 (1985).
7. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH, N.P., Crystal structure of a p53 tumor-suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
8. COOPER, D.N. and YOUSSOUFIAN, H., The CpG nucleotide and human genetic disease. Hum. Genet., 78, 151-158 (1988).
9. CORDON-CARDO, C., LATRES, E., DROBNJAK, M., OLIVA, M.R., POLLACK, D., WOODRUFF, J.M., MARECHAL, V., CHEN, J., BRENNAN, M.F. and LEVINE, A.J., Molecular abnormalities of mdm2 and p53 genes in adult soft-tissue sarcomas. Cancer Res., 54, 794-799 (1994).
10. COULONDRE, C., MILLER, J.H., FARABOUGH, P.J. and GILBERT, W., Molecular basis of base substitution hotspots in Escherichia coli. Nature (Lond.), 274, 775-780 (1978).
11. DE VOS, S., WILCZYNSKI, S.P., FLEISCHHACKER, M. and KOEFFLER, P., p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol. Oncol., 54, 205-208 (1994).
12. DUMAZ, N., DROUGARD, C., SARASIN, A. and DAYAGROSJEAN, L., Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficienl xeroderma-pigmentosum patients. Proc. nat. Acad. Sci. (Wash.), 90, 10529-10533 (1993).
13. ENJOJI, M. and HASHIMOTO, H., Diagnosis of soft-tissue sarcomas. Pathol. Res. Pract., 178, 215-226 (1984).
14. ENZINGER, P.M., LATTES, R. and TORLONI, R., Histologic typing of soft-tissue tumors. International classification of tumors, 3, WHO, Geneva (1969).
15. FELIX, C.A., KAPPEL, C.C., MITSUDOMI, T., NAU, M.M., TSOKOS, M., CROUCH, G.D., NISEN, P.D., WINICK, N.J. and HELMAN, I.J., Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res., 52, 2243-2247 (1992).
16. FLORENES, V.A., MAELANDSMO, G.M., FORUS, A., ANDREASSEN, A., MYKLEBOST, O. and FODSTAD, O., mdm2-gene amplification and transcript levels in human sarcomas: relationship to tp53-gene status. J. nat. Cancer Inst., 86, 1297-1302 (1994).
17. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor-suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
18. GRIMMOND, S.M., RAGHAVAN, D. and RUSSELL, P.J., Detection of rare point mutations in Ki-ras of human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urol. Res., 20, 121-126 (1992).
19. HOLLSTEIN, M., MARION, M.J., LEHMAN, T., WELSH, J., HARRIS, C.C., MARTEL-PLANCHE, G., KUSTERS, I. and MONTESANO, R., p53 mutations at A:T base pairs in angiosarcomas of vinyl-chloride-exposed factory workers. Carcinogenesis, 15, 1-3 (1994).
20. HOLLSTEIN, M., SHOMER, B., GREENBLATT, M.S., SOUSSI, T., HOVIG, E., MONTESANO, R. and HARRIS, C.C., Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res., 24, 141-146 (1996).
21. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
22. HOSOI, G., HARA, J., OKAMURA, T., OSUGI, Y., ISHIHARA, S., FUKUZAWA, M., OKADA, A., OKADA, S. and TAWA, A., Low frequency of the p53-gene mutations in neuroblastoma. Cancer, 72, 3087-3093 (1994).
23. IMAMURA, J., BARTRAM, C.R., BERTHOLD, F., HARMS, D., NAKAMURA, H. and KOEFFLER, H.P., Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res., 53, 4053-4058 (1993).
24. KAWAI, A., NOGUCHI, M., BEPPU, Y., YOKOYAMA, R., MUKAI, K., HIROHASHI, S., INOUE, H. and FUKUMA, H., Nuclear immunoreactions of p53 protein in soft-tissue sarcomas. Cancer, 73, 2499-2505 (1994).
25. KOMURO, H., HAYASHI, Y., KAWAMURA, M., HAYASHI, K., KANEKO, Y., KAMOSHITA, S., HANADA, R., YAMAMOTO, K., KONGO, T., YAMADA, M. and TSCHIDA, Y., Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res., 53, 5284-5288 (1993).
26. KUNKEL, T.A. and ALEXANDER, P.S., The base substitution fidelity of eukaryotic DNA polymerases. J. biol. Chem., 261, 160-166 (1985).
27. LADANYI, M., CHA, C., LEWIS, R., JHANWAR, S.C., HUVOS, A.G. and HEALEY, J.H., mdm2-gene amplification in metastatic osteosarcoma. Cancer Res., 53, 16-18 (1993).
28. LANDERS, J.E., HAINES, D.S., STRAUSS, J.F. and GEORGE, D.L., Enhanced translation: a novel mechanism of mdm2-oncogene over-expression identified in human tumor cells. Oncogene, 9, 2745-2750 (1994).
29. LATRES, E., DROBNJAK, M., POLLACK, D., OLIVA, M.R., RAMOS, M., KARPEH, M., WOODRUFF, J.M. and CORDON-CARDO, C., Chromo-some-17 abnormalities and tp53 mutations in adult soft-tissue sarcoma. Amer. J. Pathol., 145, 345-355 (1994).
30. LEACH, F.S., TOKINO, T., BURRELL, M., OLINER, J.D., SMITH, S., HILL, D.E., SIDRANSKY, D., KINZLER, K.W. and VOGELSTEIN, B., p53 mutations and mdm2 amplification in human soft-tissue sarcomas. Cancer Res., 53, 2231-2234 (1993).
31. LEVINE, A.J., The p53 tumor-suppressor gene and product. Biol. Chem. Hoppe-Seyler, 374, 227-235 (1993).
32. LINDAHL, T. and NYBERG, B., Heat-induced de-amination of cytosine residues in deoxyribonucleic acids. Biochemistry, 13, 3405-3410 (1974).
33. LIU, F.-S., KOHLER, M.F., MARKS, J.R., BAST, R.C., BOYD, J. and BERCHUCK, A., Mutation and over-expression of the p53 tumor-suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet. Gynecol., 83, 118-124 (1994).
34. MARSTON, N.J., CROOK, T. and VOUDSEN, K.H., Interaction of p53 with mdm2 is independent of E6 and does not mediate wild-type transformation-suppressor function. Oncogene, 9, 2707-2716 (1994).
35. MENON, A.G., ANDERSON, K.M., RICCARDI, V.M., CHUNG, R.Y., WHALEY, J.M., FARMER, G.E., FREIMAN, R.N., LEE, J.K. and LI, F.P., Chromosome 17p deletions and p53-gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. nat. Acad. Sci. (Wash.), 87, 5435-5439 (1990).
36. MOMAND, J., ZAMBETTI, G.P., OLSON, D.C., GEORGE, D. and LEVINE, A., The mdm2-oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245 (1992).
37. MULLIGAN, L.M., MATLASHEWSKI, G.J., SCRABLE, H.J. and CAVENEE, W.K., Mechanism of p53 loss in human sarcomas. Proc. nat. Acad. Sci. (Wash.), 87, 5863-5867 (1990).
38. OLINER, J.D., PIETENPOL, J.A., THIAGALINGAM, S., GYURIS, J., KINZLER, K.W. and VOGELSTEIN, B., Oncoprotein mdm2 conceals the activation domain of tumour-suppressor p53. Nature (Land.), 362, 857-860 (1992).
39. PATTERSON, H., GILL, S., FISHER, C., LAW, M.G., JAYATILAKE, H., FLETCHER, C.D.M., THOMAS, M., GRIMER, R., GUSTERSON, B.A. and COOPER, C.S., Abnormalities of the p53, mdm2 and dcc genes in human leiomyosarcomas. Brit. J. Cancer, 69, 1052-1058 (1994).
40. PULCIANI, S., SANTOS, E., LAUVER, A.V., LONG, L.K., AARONSON, S.A. and BARBACID, M., Oncogenes in solid human tumors. Nature (Lond), 300, 539-542 (1982).
41. SCHMUTTE, C., YANG, A.S., HEART, R.W. and JONES, P.A., Base repair of U:G mismatches at hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res., 55, 3742-3746 (1995).
42. SCINICARIELLO, F., DOLAN, M.J., NEDELCU, I., TYRING, S.K. and HILLIARD, J.K., Occurrence of human papillomavirus and p53-gene mutations in Kaposi's sarcoma. Virology, 203,153-157 (1994).
43. STRATTON, M.R., MOSS, S., WARREN, W., PATTERSON, H., CLARK, J., FISHER, C., FLETCHER, C., BALL, A., THOMAS, M., GUSTERSON, B. and COOPER, C., Mutation of the p53 gene in human soft-tissue sarcomas: association with abnormalities of the Rb1 gene. Oncogene, 5, 1297-1301 (1990).
44. SYVÄNEN, A.-C., SÖDERLUND, H., LAAKSONEN, E., BENGTSTRÖM, M., TURUNEN, M. and PALOTIE, A., N-ras mutations in acute myeloid leukemia: accurate detection by solid-phase minisequencing. Int. J. Cancer, 50, 713-718 (1992).
45. TAPAROWSKY, E., SHIMIZU, K., GOLDFARB, M. and WIGLER, M., Structure and activation of the human N-ras gene. Cell, 34, 581-586 (1983).
46. TAUBERT, H., WÜRL, P., MEYE, A., BERGER, D., THAMM, B., NEUMANN, K., HINZE, R., SCHMIDT, H. and RATH, F.-W., Molecular and immuno-histochemical p53 status in liposarcoma and malignant fibrous histiocytoma. Cancer, 76, 1187-1195 (1995).
47. THAMM, B., Direct non-isotopic sequencing of PCR products or standards. In: T. KÖhler, D. Lassner, A.-K. Rost, B. Thamm, B. Pustowoit and H. Remke (eds.), Quantitation of mRNA by polymerase chain reaction non-radioactive PCR methods (1st ed.), pp. 40-43, Springer, (1995).
48. TOGUCHIDA, J., YAMAGUCHI, T., RITCHIE, B., BEAUCHAMP, R.L., DAYTON, S.H. and HERRERA, G.E., Mutation spectrum of the p53 gene in bone and soft-tissue sarcomas. Cancer Res., 52, 6194-6199 (1992).
49. TORNALETTI, S. and PFEIFER, G.P., Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene, 10, 1493-1499 (1995).
50. VAN UNNIK, J.A.M., COINDRE, J.M., CONTESSO, G., ALBUS-LUTTER, C.E., SCHIODT, T. and GARCIA-MIRALLES, T., Grading of soft-tissue sarcomas. In: J.R. Ryan and L.O. Baker (eds.), Experience of the EORTC soft-tissue and bone sarcoma treatment, pp. 7-13, Kluwer, Dordrecht (1988).
51. VOGAN, K., BENSTEIN, M., LECLERC, J.-M., BRISSON, L., BROSSARD, J., BRODEUR, G.M., PELLETIER, J. and GROS, P., Absence of p53 mutations in primary neuroblastomas. Cancer Res., 53, 5269-5273 (1993).
52. WIETHEGE, T., VOSS, B. and MÜLLER, K.-M., Detection of mdm2 proto-oncogene in paraffin-embedded human bronchial epithelium. J. Cancer Res. clin. Oncol., 120, 252-255 (1994).
53. WILKE, W. and ROBINSON, R., H-ras point mutations in soft-tissue sarcomas. Mod. Pathol., 6, 129-132 (1993).
54. WU, C. and MAEDA, N., Inequality in mutation rates of the two strands of DNA. Nature (Land.), 327, 169-170 (1987).